Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

4.1K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.1K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

2.2K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

820
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
820
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

3.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

4.0K
The pathophysiology of pneumonia involves the following steps:
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Mediastinal Lymph Node Dynamics Associate with Mortality and Fibrosis Progression in Fibrotic ILD.

Chest·2026
Same authorSame journal

Editors' Recognition for Reviewing in 2025.

Journal of thoracic imaging·2026
Same author

Not a Fluke: Pulmonary Manifestations of Parasitic Infection.

Journal of thoracic imaging·2026
Same author

Editors' Recognition for Reviewing in 2025.

Journal of thoracic imaging·2026
Same author

ACR Appropriateness Criteria® Preprocedural Chest or Cardiac Imaging for Cardiothoracic Surgery.

Journal of the American College of Radiology : JACR·2026
Same author

Radiologic Features of Airways Disease Are Associated With Interstitial Lung Abnormality Progression.

Respiratory care·2026

Related Experiment Video

Updated: Mar 23, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

1.3K

Idiopathic Pulmonary Fibrosis.

Maria D Martin1, Jonathan H Chung, Jeffrey P Kanne

  • 1*Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, WI †Department of Radiology, The University of Chicago Medicine, Chicago, IL.

Journal of Thoracic Imaging
|April 5, 2016
PubMed
Summary

Idiopathic pulmonary fibrosis (IPF) is a common lung disease with a poor prognosis. High-resolution CT scans can diagnose IPF by identifying a usual interstitial pneumonia (UIP) pattern, often negating the need for surgical biopsy.

More Related Videos

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

2.2K
Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
06:29

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

3.2K

Related Experiment Videos

Last Updated: Mar 23, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

1.3K
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

2.2K
Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
06:29

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

3.2K

Area of Science:

  • Pulmonology
  • Radiology
  • Pathology

Background:

  • Idiopathic pulmonary fibrosis (IPF) is the most prevalent fibrosing lung disease, characterized by a grim prognosis.
  • IPF presents histopathologically as usual interstitial pneumonia (UIP).

Purpose of the Study:

  • To review the clinical, CT, and histopathologic features of IPF.
  • To discuss the prognostic implications of CT findings in IPF.
  • To describe complications associated with IPF.

Main Methods:

  • Review of clinical data.
  • Analysis of high-resolution computed tomography (HRCT) findings.
  • Examination of histopathologic features.

Main Results:

  • A UIP pattern on HRCT, characterized by subpleural and basal predominant reticulation with honeycombing, is key for diagnosis.
  • High-confidence radiologic diagnosis of UIP on HRCT often obviates the need for surgical biopsy.
  • Distinguishing UIP from other fibrosing lung diseases like nonspecific interstitial pneumonia or chronic hypersensitivity pneumonitis is crucial.

Conclusions:

  • Radiologists play a critical role in identifying the UIP pattern on HRCT for accurate IPF diagnosis.
  • Understanding CT findings is essential for assessing IPF prognosis.
  • Recognition of IPF and its complications is vital for patient management.